Clinical Trial Update: Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hypofractionated intensity-modulated chemoradiotherapy for locally advanced stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Stage III Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN